Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) and Growth Differentiation Factor-15 (GDF-15) Levels Are Significantly Associated with Endothelial Injury Indices in Adult Allogeneic Hematopoietic Cell Transplantation Recipients
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms25010231 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Eleni Gavriilaki und 18 weiteren Autor:innen. Beteiligte Einrichtung: Second Propedeutic Department of Internal Medicine, Hippocration Hospital, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Graft vs Host Disease, Thrombotic Microangiopathies. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-TMA) and graft-versus-host disease (GvHD) represent life-threatening syndromes after allogeneic hematopoietic stem cell transplantation (allo-HSCT). In both conditions, endothelial dysfunction is a common denominator, and development of relevant biomarkers is of high importance for both diagnosis and prognosis. Despite the fact that soluble urokinase plasminogen activator receptor (suPAR) and growth differentiation factor-15 (GDF-15) have been determined as endothelial injury indices in various clinical settings, their role in HSCT-related complications remains unexplored. In this context, we used immunoenzymatic methods to measure suPAR and GDF-15 levels in HSCT-TMA, acute and/or chronic GVHD, control HSCT recipients, and apparently healthy individuals of similar age and gender. We found considerably greater SuPAR and GDF-15 levels in HSCT-TMA and GVHD patients compared to allo-HSCT and healthy patients. Both GDF-15 and suPAR concentrations were linked to EASIX at day 100 and last follow-up. SuPAR was associated with creatinine and platelets at day 100 and last follow-up, while GDF-15 was associated only with platelets, suggesting that laboratory values do not drive EASIX. SuPAR, but not GDF-15, was related to soluble C5b-9 levels, a sign of increased HSCT-TMA risk. Our study shows for the first time that suPAR and GDF-15 indicate endothelial damage in allo-HSCT recipients. Rigorous validation of these biomarkers in many cohorts may provide utility for their usefulness in identifying and stratifying allo-HSCT recipients with endothelial cell impairment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Second Propedeutic Department of Internal Medicine, Hippocration Hospital, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece.
- BMT Unit, Hematology Department, George Papanicolaou General Hospital, 57010 Thessaloniki, Greece.
- Department of Hematology, Metropolitan Hospital, Neo Faliro, 18547 Athens, Greece.
- Hematology Laboratory-Blood Bank, Aretaieion Hospital, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.
- First Department of Pediatrics, School of Medicine, National and Kapodistrian University of Athens, 15772 Athens, Greece.
ORCID-Profile: Eleni Gavriilaki, Ioannis Papassotiriou
Zitieren
APA
Gavriilaki, E., Bousiou, Z., Batsis, I., Vardi, A., Mallouri, D., Koravou, E. E., Konstantinidou, G., Spyridis, N., Karavalakis, G., Noli, F., Patriarcheas, V., Masmanidou, M., Touloumenidou, T., Papalexandri, A., Poziopoulos, C., Yannaki, E., Sakellari, I., Politou, M., & Papassotiriou, I. (2023). Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) and Growth Differentiation Factor-15 (GDF-15) Levels Are Significantly Associated with Endothelial Injury Indices in Adult Allogeneic Hematopoietic Cell Transplantation Recipients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25010231
Vancouver
Gavriilaki E, Bousiou Z, Batsis I, Vardi A, Mallouri D, Koravou EE, et al. Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) and Growth Differentiation Factor-15 (GDF-15) Levels Are Significantly Associated with Endothelial Injury Indices in Adult Allogeneic Hematopoietic Cell Transplantation Recipients. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms25010231
BibTeX
@article{Gavriilaki2023,
author = {Gavriilaki, Eleni and Bousiou, Zoi and Batsis, Ioannis and Vardi, Anna and Mallouri, Despina and Koravou, Evaggelia-Evdoxia and Konstantinidou, Georgia and Spyridis, Nikolaos and Karavalakis, Georgios and Noli, Foteini and Patriarcheas, Vasileios and Masmanidou, Marianna and Touloumenidou, Tasoula and Papalexandri, Apostolia and Poziopoulos, Christos and Yannaki, Evangelia and Sakellari, Ioanna and Politou, Marianna and Papassotiriou, Ioannis},
title = {Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) and Growth Differentiation Factor-15 (GDF-15) Levels Are Significantly Associated with Endothelial Injury Indices in Adult Allogeneic Hematopoietic Cell Transplantation Recipients},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms25010231}
}
EUVIMED